Merck (MRK), the New Jersey-based maker of widely-used cancer treatment Keytruda, filed a lawsuit Tuesday in a federal court in Washington seeking to block the drug negotiation program, created by the Inflation Reduction Act of 2022, from going into effect in 2026.
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
UCLA’s new Affordability Initiative will award four-year scholarships to up to 35 California resident students each year starting in 2024. The $20,000 scholarships, funded by a $15 million donation from UCLA alumnus Peter Merlone, will be distributed to recipients over the course of four years, according to a press release from UCLA Newsroom.
Editor’s note: Editorials do not represent the views of the Daily Bruin as a whole. The board encourages readers to respond to our editorials at dailybruin.com/submit.